These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 11742876)

  • 1. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques.
    Dhore CR; Cleutjens JP; Lutgens E; Cleutjens KB; Geusens PP; Kitslaar PJ; Tordoir JH; Spronk HM; Vermeer C; Daemen MJ
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1998-2003. PubMed ID: 11742876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis.
    Schoppet M; Al-Fakhri N; Franke FE; Katz N; Barth PJ; Maisch B; Preissner KT; Hofbauer LC
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4104-12. PubMed ID: 15292354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment.
    Giuliani N; Bataille R; Mancini C; Lazzaretti M; Barillé S
    Blood; 2001 Dec; 98(13):3527-33. PubMed ID: 11739153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF-1, RANKL and OPG regulate osteoclastogenesis during murine tooth eruption.
    Heinrich J; Bsoul S; Barnes J; Woodruff K; Abboud S
    Arch Oral Biol; 2005 Oct; 50(10):897-908. PubMed ID: 16137499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.
    Huang L; Xu J; Wood DJ; Zheng MH
    Am J Pathol; 2000 Mar; 156(3):761-7. PubMed ID: 10702390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat.
    Silvestrini G; Ballanti P; Patacchioli F; Leopizzi M; Gualtieri N; Monnazzi P; Tremante E; Sardella D; Bonucci E
    J Mol Histol; 2005 Feb; 36(1-2):59-67. PubMed ID: 15704000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoprotegerin and rank ligand expression in prostate cancer.
    Brown JM; Corey E; Lee ZD; True LD; Yun TJ; Tondravi M; Vessella RL
    Urology; 2001 Apr; 57(4):611-6. PubMed ID: 11306358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of bone-regulatory proteins in human valve allografts.
    Shetty R; Pepin A; Charest A; Perron J; Doyle D; Voisine P; Dagenais F; Pibarot P; Mathieu P
    Heart; 2006 Sep; 92(9):1303-8. PubMed ID: 16449517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice.
    Bennett BJ; Scatena M; Kirk EA; Rattazzi M; Varon RM; Averill M; Schwartz SM; Giachelli CM; Rosenfeld ME
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2117-24. PubMed ID: 16840715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand.
    Yamamoto Y; Udagawa N; Matsuura S; Nakamichi Y; Horiuchi H; Hosoya A; Nakamura M; Ozawa H; Takaoka K; Penninger JM; Noguchi T; Takahashi N
    Endocrinology; 2006 Jul; 147(7):3366-74. PubMed ID: 16627581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.
    Lubberts E; Oppers-Walgreen B; Pettit AR; Van Den Bersselaar L; Joosten LA; Goldring SR; Gravallese EM; Van Den Berg WB
    Arthritis Rheum; 2002 Nov; 46(11):3055-64. PubMed ID: 12428250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification.
    Kaden JJ; Bickelhaupt S; Grobholz R; Haase KK; Sarikoç A; Kiliç R; Brueckmann M; Lang S; Zahn I; Vahl C; Hagl S; Dempfle CE; Borggrefe M
    J Mol Cell Cardiol; 2004 Jan; 36(1):57-66. PubMed ID: 14734048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin (OPG) and RANKL expression and distribution in developing human craniomandibular joint.
    Carda C; Silvestrini G; Gomez de Ferraris ME; Peydró A; Bonucci E
    Tissue Cell; 2005 Jun; 37(3):247-55. PubMed ID: 15899507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunolocalization of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin (OPG) in Meckel's cartilage compared with developing endochondral bones in mice.
    Sakakura Y; Tsuruga E; Irie K; Hosokawa Y; Nakamura H; Yajima T
    J Anat; 2005 Oct; 207(4):325-37. PubMed ID: 16191162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin.
    Collin-Osdoby P
    Circ Res; 2004 Nov; 95(11):1046-57. PubMed ID: 15564564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
    Shalhoub V; Faust J; Boyle WJ; Dunstan CR; Kelley M; Kaufman S; Scully S; Van G; Lacey DL
    J Cell Biochem; 1999 Feb; 72(2):251-61. PubMed ID: 10022507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
    Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
    Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure.
    Ueland T; Yndestad A; Øie E; Florholmen G; Halvorsen B; Frøland SS; Simonsen S; Christensen G; Gullestad L; Aukrust P
    Circulation; 2005 May; 111(19):2461-8. PubMed ID: 15883214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis.
    Min H; Morony S; Sarosi I; Dunstan CR; Capparelli C; Scully S; Van G; Kaufman S; Kostenuik PJ; Lacey DL; Boyle WJ; Simonet WS
    J Exp Med; 2000 Aug; 192(4):463-74. PubMed ID: 10952716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.
    Kotake S; Udagawa N; Hakoda M; Mogi M; Yano K; Tsuda E; Takahashi K; Furuya T; Ishiyama S; Kim KJ; Saito S; Nishikawa T; Takahashi N; Togari A; Tomatsu T; Suda T; Kamatani N
    Arthritis Rheum; 2001 May; 44(5):1003-12. PubMed ID: 11352231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.